TaiMed Biologics
Manufacturing · Taiwan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
No. 18 Ln. 15 Shengyi 5th Rd, Zhubei Cit...Phone Number
(949) 331-3225Website
www.taimedbiologics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About TaiMed Biologics
TaiMed Biologics is a leading biopharmaceutical company in Taiwan specializing in the development of biologics, particularly for HIV treatment. The company offers contract development and manufacturing organization (CDMO) services to facilitate the transition of products from clinical trials to commercial availability. Its notable products include Trogarzo, the first humanized monoclonal antibody for HIV-1 infection, and the innovative TMB-365/TMB-380 combination therapy. TaiMed Biologics aims to serve healthcare providers and patients in need of advanced HIV therapies and precision medicine solutions.Explore more
TaiMed Biologics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TaiMed Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if TaiMed Biologics has recently received funding, and reach out quickly before it becomes old news!
Click to see if TaiMed Biologics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once TaiMed Biologics has new funding data
Website visits: Recent activity has been detected on your website
TaiMed Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at TaiMed Biologics
Check out if TaiMed Biologics is spiking on competitors!
Product Launch: Get notified when TaiMed Biologics launches new products
Earning: See what the market has to say on TaiMed Biologics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined TaiMed Biologics as Masked Content
Find 2 more new buyers
Compare Similar Companies to TaiMed Biologics
Compare insights from companies similar to TaiMed Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TaiMed Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
TaiMed Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about TaiMed Biologics.
TaiMed Biologics Tech Stack
A closer look at the technologies used by TaiMed Biologics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events
Event
TaiMed Biologics News & Media
TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025
TMB-365/TMB-380 Combination Demonstrates Viral Suspension Without the Need for Susceptibility Screening TaiMed Biologics will reshape HIV treatment management and seeks strategic collaborations with global pharmaceutical partners for the commercialization of its long-acting HIV maintenance therapy TAIPEI, March 18, 2025 /PRNewswire/ -- TaiMed Biologics (4147 TWO), an innovation-driven biotech company, has Phase 2a clinical study evaluating TMB-365/TMB-380 long-acting dual bNAb regimen for HIV maTaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment
Company champions long-acting HIV therapy with new biologic drug TMB-365/380 combination; after favorable results of Phase 1b/2a, company plans to accelerate Phase 2 clincial study to expedite path to market TAIPEI, Oct. 16, 2023 /PRNewswire/ -- TaiMed Biologics, an innovation-driven biotech company dedicated to serving unmet healthcare needs, has announced favorable results and the successful completion of the sentinel group in its phase 1b/2a clinical study evaluating its groundbreaking new tr
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TaiMed Biologics
Sign Up For FreeTo access detailed company insights
TaiMed Biologics is a leading biopharmaceutical company in Taiwan specializing in the development of biologics, particularly for HIV treatment. The company offers contract development and manufacturing organization (CDMO) services to facilitate the transition of products from clinical trials to commercial availability. Its notable products include... Read More
